ebook Munafa Stock Market Course + Intraday & FNO calls  

       

HALO announcements Halozyme Therapeutics, Inc. announcements and dividends declared NASDAQ

Halozyme Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Halozyme Therapeutics, Inc. HALO

Halozyme Therapeutics, Inc. HALO listed on NASDAQ and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Halozyme Therapeutics, Inc. HALO

Bull of the Day: Halozyme Therapeutics (HALO)
The Street bailed on HALO in the spring, right before a summer rally to new highs on strong growth
Announcement as on 23 September 2025

If You Invested 00 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Announcement as on 18 September 2025

Here's How Much a 00 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Announcement as on 02 September 2025

Here's How Much a 00 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Announcement as on 02 September 2025

Halozyme Therapeutics (HALO) Surges 5.6%: Is This an Indication of Further Gains?
Halozyme Therapeutics HALO shares ended the last trading session 5.6% higher at .36. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's
Announcement as on 17 January 2024

Announcements by Halozyme Therapeutics, Inc. first page | Next page |

HALO Halozyme Therapeutics, Inc. current price & indicator signals

Moving Averages for Halozyme Therapeutics, Inc.

  • 5Day Average: 65.11
  • 12Day Average: 68.83
  • 20Day Average: 69.24
  • 50Day Average: 68.18
  • 100Day Average: 68.39
  • 150Day Average: 64.05
  • 200Day Average: 63.16

HALO Indicators & signals

Indicator MACD (12,26,9)

67.42, 68.28, 0.11
Indicator MACD is in negative zone

Indicator ADX (14)

37.82, 14.8, 32.8
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of HALO Halozyme Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 63.33 62.59 to 63.98 0.68% 0.67 times
04 Thu Dec 2025 62.90 61.06 to 66.00 -2.72% 1.05 times
03 Wed Dec 2025 64.66 64.50 to 67.10 -2.83% 1.23 times
02 Tue Dec 2025 66.54 66.38 to 68.60 -2.29% 0.8 times
01 Mon Dec 2025 68.10 68.01 to 72.00 -4.62% 0.98 times
28 Fri Nov 2025 71.40 70.49 to 72.78 -1.73% 0.47 times
26 Wed Nov 2025 72.66 72.17 to 74.25 -0.22% 0.56 times
25 Tue Nov 2025 72.82 72.27 to 74.22 -1.59% 1.04 times
24 Mon Nov 2025 74.00 69.90 to 74.01 5.2% 2.47 times
21 Fri Nov 2025 70.34 68.09 to 70.76 1.99% 0.95 times
20 Thu Nov 2025 68.97 68.73 to 70.81 -1.82% 0.45 times
19 Wed Nov 2025 70.25 68.96 to 70.53 0.21% 0.75 times

Videos related to: HALO announcements Halozyme Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

HALO announcements Halozyme Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top